NCT04893304

Brief Summary

This prospective randomized comparative split study will be conducted at the outpatient clinic, Dermatology department, Faculty of Medicine, Cairo University and will include 20 patients with acanthosis nigricans in otherwise healthy individuals which will be recruited and assessed for eligibility for inclusion according to the above criteria.

  • Evaluation: All patients will be subjected to: Pre-operative preparation:
  • Informed written consent will be taken from every patient prior to the study.
  • Detailed history taking including onset, course, duration of the disease and occupation (sun-exposed or not), predisposing factors, history of keloid tendency, associated diseases and previous treatments.
  • Assessment of skin type, BMI, degree of AN, HbA1C, site of lesions in all patients and degree of improvement.
  • Photography: will evaluate the clinical response to treatment for each patient Photos will be taken before starting the study, before every session, and two weeks after the last session.
  • Melanin index (MI) will be measured using reflectance spectrophotometer in order to assess the degree of hyperpigmentation before starting the study and two weeks after the last session. Research Template 8 Final Version: April 2019
  • Acanthosis Nigricans Area and Severity Index (ANASI) score (Zaki et al., 2018) will be done for all patients before starting the study and two weeks after the last session.
  • Patient satisfaction score will be assessed before starting the study and two weeks after the last session.
  • Patient evaluation (clinical percentage of improvement). Operation : One side of the affected area will be randomly assigned to fractional CO2 laser every four weeks for three months. The other side will be assigned to Q-switched Nd:YAG laser every four weeks for three months. Method of randomization: Using closed envelopes containing cards with fractional CO2 Rt and fractional CO2 Lt and the patient will draw one of them blindly. The assessment will be done by blinded investigator. Post-operative: Patients will be instructed to avoid sun exposure for one week after the session and regular use of sun block in between sessions.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

May 30, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

May 19, 2021

Status Verified

May 1, 2021

Enrollment Period

11 months

First QC Date

April 25, 2021

Last Update Submit

May 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • patient evaluation

    Acanthosis nigricans area and severity index is scoring system used to assess patients before the session and after the session to assess finally the improvement

    3 months

Study Arms (1)

1 group of 20 patients doing both types of lasers on 2 sites

OTHER

comparing both types of laser

Device: co2 laser

Interventions

co2 laserDEVICE

types of laser

Also known as: NdYAG laser
1 group of 20 patients doing both types of lasers on 2 sites

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age more than 18 years old
  • both genders
  • skin type III to V
  • controlled diabetus

You may not qualify if:

  • pregnancy and lactation
  • scarring
  • active skin infections
  • endocrinal disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acanthosis Nigricans

Interventions

Lasers, Gas

Condition Hierarchy (Ancestors)

MelanosisHyperpigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

LasersOptical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principale investigator

Study Record Dates

First Submitted

April 25, 2021

First Posted

May 19, 2021

Study Start

May 30, 2021

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

May 19, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

results and discussion can be shared

Time Frame
after finishing the paper and will be always be available
Access Criteria
through the pubmed